Biograil Raises €20 Million to Push Oral Biologic Delivery Into Clinics
Copenhagen's Biograil raises €20 million from Verve Ventures, Megatrend Invest and HTGF to advance its capsule-based BIONDD® oral delivery platform toward Phase 1 trials.
Topic
Oral Drug Delivery
Topic
Oral Drug Delivery
Biograil Raises €20 Million to Move Oral Drug Platform Toward Trials
Copenhagen-based Biograil raised €20 million to advance its capsule-based BIONDD oral delivery platform through preclinical work…